A M E Bruynzeel
Overview
Explore the profile of A M E Bruynzeel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huguet F, Bouchart C, Bruynzeel A, Hawkins M, Mukherjee S, Nuyttens J, et al.
Ann Oncol
. 2024 Jul;
35(8):749-750.
PMID: 39048262
No abstract available.
2.
Doppenberg D, Lagerwaard F, van Dieren S, Meijerink M, van der Vliet J, Besselink M, et al.
Front Oncol
. 2023 Jun;
13:1149961.
PMID: 37324027
Background: The role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is evolving. However adequate patient selection criteria for SABR...
3.
van Goor I, Daamen L, Besselink M, Bruynzeel A, Busch O, Cirkel G, et al.
Trials
. 2023 Jan;
24(1):55.
PMID: 36694252
No abstract available.
4.
Doppenberg D, Besselink M, van Eijck C, Intven M, Koerkamp B, Kazemier G, et al.
BMC Cancer
. 2023 Jan;
23(1):70.
PMID: 36670370
No abstract available.
5.
Doppenberg D, Besselink M, van Eijck C, Intven M, Koerkamp B, Kazemier G, et al.
BMC Cancer
. 2022 Dec;
22(1):1363.
PMID: 36581914
Background: Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic) pancreatic ductal adenocarcinoma (PDAC). These patients are currently treated...
6.
van Goor I, Daamen L, Besselink M, Bruynzeel A, Busch O, Cirkel G, et al.
Trials
. 2022 Oct;
23(1):913.
PMID: 36307892
Background: Disease recurrence is the main cause of mortality after resection of pancreatic ductal adenocarcinoma (PDAC). In 20-30% of resected patients, isolated local PDAC recurrence occurs. Retrospective studies have suggested...
7.
Numan T, Kulik S, Moraal B, Reijneveld J, Stam C, de Witt Hamer P, et al.
Sci Rep
. 2021 Sep;
11(1):18990.
PMID: 34556701
Non-invasively measured brain activity is related to progression-free survival in glioma patients, suggesting its potential as a marker of glioma progression. We therefore assessed the relationship between brain activity and...
8.
Botman R, Tetar S, Palacios M, Slotman B, Lagerwaard F, Bruynzeel A
Clin Transl Radiat Oncol
. 2019 Jul;
18:140-145.
PMID: 31341990
The latest development in radiation oncology departments towards high precision and adaptive radiation therapy is the clinical introduction of magnetic resonance image guided radiation therapy (MRgRT). Early 2016, patient treatment...
9.
Bohoudi O, Bruynzeel A, Senan S, Cuijpers J, Slotman B, Lagerwaard F, et al.
Radiother Oncol
. 2017 Aug;
125(3):439-444.
PMID: 28811038
Background And Purpose: To implement a robust and fast stereotactic MR-guided adaptive radiation therapy (SMART) online strategy in locally advanced pancreatic cancer (LAPC). Material And Methods: SMART strategy for plan...
10.
Bruynzeel A, Niessen H, Bronzwaer J, van der Hoeven J, Berkhof J, Bast A, et al.
Br J Cancer
. 2007 Oct;
97(8):1084-9.
PMID: 17940501
The purpose of this study was to investigate the cardioprotective effect of the semisynthetic flavonoid 7-monohydroxyethylrutoside (monoHER) on doxorubicin (DOX)-induced cardiotoxicity in a phase II study in patients with metastatic...